Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease.

Cappelli B, Volt F, Tozatto-Maio K, Scigliuolo GM, Ferster A, Dupont S, Pinto Simões B, Al-Seraihy A, Aljurf MD, Almohareb F, Belendez C, Matthes S, Dhedin N, Pondarre C, Dalle JH, Bertrand Y, Vannier JP, Kuentz M, Lutz P, Michel G, Rafii H, Neven B, Zecca M, Bader P, Cavazzana M, Labopin M, Locatelli F, Magnani A, Ruggeri A, Rocha V, Bernaudin F, de La Fuente J, Corbacioglu S, Gluckman E.

Haematologica. 2019 Apr 24. pii: haematol.2019.216788. doi: 10.3324/haematol.2019.216788. [Epub ahead of print]


Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC).

Farge D, Cajfinger F, Falvo N, Berremili T, Couturaud F, Bensaoula O, Védrine L, Bensalha H, Bonnet I, Péré-Vergé D, Coudurier M, Li V, Rafii H, Benzidia I, Connors JM, Resche-Rigon M.

Oncotarget. 2018 Jun 5;9(43):26990-26999. doi: 10.18632/oncotarget.25454. eCollection 2018 Jun 5.


Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.

Hayashi H, Ruggeri A, Volt F, Cornelissen JJ, Socié G, Sengeloev H, Michallet M, Karakasis D, Petersen E, Cahn JY, Veelken H, Mercier M, Rohrlich PS, Rafii H, Kenzey C, Xavier E, Duarte RF, Basak GW, Rocha V, Gluckman E; Eurocord and the Complications and Quality of Life WP of EBMT.

Bone Marrow Transplant. 2018 Apr;53(4):417-421. doi: 10.1038/s41409-017-0061-9. Epub 2018 Jan 12. No abstract available.


Endothelial and Circulating Progenitor Cells in Hematological Diseases and Allogeneic Hematopoietic Stem Cell Transplantation.

Ruggeri A, Paviglianiti A, Volt F, Kenzey C, Rafii H, Rocha V, Gluckman E.

Curr Med Chem. 2018;25(35):4535-4544. doi: 10.2174/0929867324666171012110244. Review.


Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks.

Rafii H, Bernaudin F, Rouard H, Vanneaux V, Ruggeri A, Cavazzana M, Gauthereau V, Stanislas A, Benkerrou M, De Montalembert M, Ferry C, Girot R, Arnaud C, Kamdem A, Gour J, Touboul C, Cras A, Kuentz M, Rieux C, Volt F, Cappelli B, Maio KT, Paviglianiti A, Kenzey C, Larghero J, Gluckman E.

Haematologica. 2017 Jun;102(6):976-983. doi: 10.3324/haematol.2016.163055. Epub 2017 Mar 16.


Changing Trends of Unrelated Umbilical Cord Blood Transplantation for Hematologic Diseases in Patients Older than Fifty Years: A Eurocord-Center for International Blood and Marrow Transplant Research Survey.

Rafii H, Ruggeri A, Volt F, Brunstein CG, Carreras J, Eapen M, Gluckman E, Weisdorf DJ.

Biol Blood Marrow Transplant. 2016 Sep;22(9):1717-1720. doi: 10.1016/j.bbmt.2016.05.015. Epub 2016 May 21. No abstract available.


Impact of chimaerism analysis and kinetics on allogeneic haematopoietic stem cell transplantation outcome after conventional and reduced-intensity conditioning regimens.

Michallet AS, Fürst S, Le QH, Dubois V, Praire A, Nicolini F, Thomas X, Rafii H, Gebuhrer L, Michallet M.

Br J Haematol. 2005 Mar;128(5):676-89.


An iodinated derivative of moclobemide as potential radioligand for brain MAO-A exploration.

Rafii H, Chalon S, Ombetta JE, Frangin Y, Pourcelot L, Besnard JC, Bodard S, Guilloteau D.

Life Sci. 1996;58(14):1159-69.


[Spontaneous pneumothorax disclosing pulmonary sarcoidosis].

Piaton E, Rafii H, Aoun C, Saugier B, Brune J.

Presse Med. 1995 Nov 11;24(34):1621. French. No abstract available.


Synthesis and characterization of [125I]N-(2-aminoethyl)-4-iodobenzamide as a selective monoamine oxidase B inhibitor.

Rafii H, Chalon S, Ombetta JE, Frangin Y, Garreau L, Dognon AM, Lena I, Bodard S, Vilar MP, Besnard JC, et al.

Nucl Med Biol. 1995 Jul;22(5):617-23.


Supplemental Content

Support Center